Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111 in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry

Hafsah Nabi; Bente Glintborg; Anne Gitte Loft; Oliver Hendricks; Jens Kristian Pedersen; Søren Andreas Just; R Ahmed; K. Danebod; Heidi Lausten Munk; Ada Colic; Asta Linauskas; D Jensen; L. Christensen; N Manilo; Niels  Lomborg; S. Kristensen; Frank Mehnert; Niels Steen Krogh; Merete Lund Hetland

Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111 in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry

Hafsah Nabi^*, Bente Glintborg, Anne Gitte Loft, Oliver Hendricks, Jens Kristian Pedersen, Søren Andreas Just, R Ahmed, K. Danebod, Heidi Lausten Munk, Ada Colic, Asta Linauskas, D Jensen, L. Christensen, N Manilo, Niels Lomborg, S. Kristensen, Frank Mehnert, Niels Steen Krogh, Merete Lund Hetland

^*Kontaktforfatter

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning › peer review

Originalsprog	Engelsk
Publikationsdato	jun. 2021
Status	Udgivet - jun. 2021
Begivenhed	EULAR 2021 Virtual Congress - Varighed: 2. jun. 2021 → 5. jun. 2021

Konference

Konference	EULAR 2021 Virtual Congress
Periode	02/06/2021 → 05/06/2021

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Nabi, H., Glintborg, B., Loft, A. G., Hendricks, O., Pedersen, J. K., Just, S. A., Ahmed, R., Danebod, K., Munk, H. L., Colic, A., Linauskas, A., Jensen, D., Christensen, L., Manilo, N., Lomborg, N., Kristensen, S., Mehnert, F., Krogh, N. S., & Hetland, M. L. (2021). Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111 in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry. Poster session præsenteret på EULAR 2021 Virtual Congress.

Nabi, Hafsah ; Glintborg, Bente ; Loft, Anne Gitte et al. / Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111 in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry. Poster session præsenteret på EULAR 2021 Virtual Congress.

@conference{56f954dd825a451d8c11e08da085f1fb,

title = "Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111 in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry",

author = "Hafsah Nabi and Bente Glintborg and Loft, {Anne Gitte} and Oliver Hendricks and Pedersen, {Jens Kristian} and Just, {S{\o}ren Andreas} and R Ahmed and K. Danebod and Munk, {Heidi Lausten} and Ada Colic and Asta Linauskas and D Jensen and L. Christensen and N Manilo and Niels Lomborg and S. Kristensen and Frank Mehnert and Krogh, {Niels Steen} and Hetland, {Merete Lund}",

year = "2021",

month = jun,

language = "English",

note = "EULAR 2021 Virtual Congress ; Conference date: 02-06-2021 Through 05-06-2021",

}

Nabi, H, Glintborg, B, Loft, AG, Hendricks, O , Pedersen, JK , Just, SA, Ahmed, R, Danebod, K, Munk, HL, Colic, A, Linauskas, A, Jensen, D, Christensen, L, Manilo, N, Lomborg, N, Kristensen, S, Mehnert, F, Krogh, NS & Hetland, ML 2021, 'Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111 in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry', EULAR 2021 Virtual Congress, 02/06/2021 - 05/06/2021.

Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111 in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry. / Nabi, Hafsah; Glintborg, Bente; Loft, Anne Gitte et al.
2021. Poster session præsenteret på EULAR 2021 Virtual Congress.

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning › peer review

TY - CONF

T1 - Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111 in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry

AU - Nabi, Hafsah

AU - Glintborg, Bente

AU - Loft, Anne Gitte

AU - Hendricks, Oliver

AU - Pedersen, Jens Kristian

AU - Just, Søren Andreas

AU - Ahmed, R

AU - Danebod, K.

AU - Munk, Heidi Lausten

AU - Colic, Ada

AU - Linauskas, Asta

AU - Jensen, D

AU - Christensen, L.

AU - Manilo, N

AU - Lomborg, Niels

AU - Kristensen, S.

AU - Mehnert, Frank

AU - Krogh, Niels Steen

AU - Hetland, Merete Lund

PY - 2021/6

Y1 - 2021/6

M3 - Poster

T2 - EULAR 2021 Virtual Congress

Y2 - 2 June 2021 through 5 June 2021

ER -

Nabi H, Glintborg B, Loft AG, Hendricks O , Pedersen JK , Just SA et al.. Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111 in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry. 2021. Poster session præsenteret på EULAR 2021 Virtual Congress.